Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 5.66
-0.55 (-8.79%)
Oct 22, 2026, 3:40 PM HKT
Laekna Revenue
Laekna had revenue of 150.28M CNY in the half year ending June 30, 2026, with 36,914.04% growth. This brings the company's total for the last twelve months to 257.00M. In the year 2025, Laekna had annual revenue of 106.72M. That makes Laekna the 29,881st largest company in the world by revenue and 1,785th in Hong Kong.
Revenue (ttm)
257.00M CNY
Revenue Growth
n/a
P/S Ratio
8.91
Revenue / Employee
3.10M CNY
Employees
83
Market Cap
2.41B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 106.72M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 280.00K | 169.00K | 152.25% |
| Dec 31, 2021 | 111.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viva Biotech Holdings | 2.20B |
| Frontage Holdings | 2.18B |
| Mabpharm | 888.77M |
| Antengene Corporation | 652.54M |
| Medtide | 635.93M |
| BioDlink International Company | 582.45M |
| Shanghai Bao Pharmaceuticals | 19.67M |
| HJ Science | 16.30M |
Laekna News
- 1 month ago - Laekna Earnings release: H1 2026 - Filings
- 1 month ago - Laekna Quarterly report: H1 2026 - Filings
- 7 months ago - Laekna Earnings release: H2 2025 - Filings
- 7 months ago - Laekna Annual report: H2 2025 - Filings